Dimensional Fund Advisors Portfolio holdings
Dimensional Fund Advisors (DFA), founded in 1981 by David Booth and Rex Sinquefield and headquartered in Austin, Texas, is an investment management firm renowned for its evidence-based, low-cost approach to investing, grounded in academic research from Nobel laureates like Eugene Fama and Kenneth French. Managing hundreds of billions in assets, DFA focuses on systematic, passive strategies that tilt toward factors like small-cap, value, and profitability stocks, primarily through mutual funds and institutional portfolios rather than retail brokerage services. The firm’s philosophy eschews market timing and stock picking, instead emphasizing diversification and efficient market exposure, often requiring investors to access its funds through approved financial advisors. With a global presence and a reputation for disciplined, data-driven investing, DFA has carved a unique niche in the industry, blending academic rigor with practical application.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$214M |
| 2 |
Verizon
VZ
|
+$148M |
| 3 |
Otis Worldwide
OTIS
|
+$142M |
| 4 |
Baidu
BIDU
|
+$124M |
| 5 |
Alibaba
BABA
|
+$120M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$324M |
| 2 |
Amazon
AMZN
|
+$313M |
| 3 |
Bank of America
BAC
|
+$264M |
| 4 |
AGN
Allergan plc
AGN
|
+$259M |
| 5 |
Wells Fargo
WFC
|
+$257M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.39% |
| 2 | Financials | 16.29% |
| 3 | Industrials | 12.76% |
| 4 | Healthcare | 11.61% |
| 5 | Consumer Discretionary | 11.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
776
Arcosa
ACA
$7.12B
| $77.5M | 0.03% |
1,835,585
+181,363
| +11% | +$6.98M |
|
777
Eversource Energy
ES
$28.2B
| $77.3M | 0.03% |
928,387
-57,179
| -6% | -$4.74M |
|
778
TriNet
TNET
$3.27B
| $77M | 0.03% |
1,263,936
+19,264
| +2% | +$962K |
|
779
First Industrial Realty Trust
FR
$8.73B
| $77M | 0.03% |
2,003,046
+42,371
| +2% | +$1.55M |
|
780
Charles River Laboratories
CRL
$11.4B
| $76.9M | 0.03% |
441,358
-31,778
| -7% | -$5.07M |
|
781
ITT
ITT
$17.1B
| $76.9M | 0.03% |
1,309,210
+6,436
| +0.5% | +$341K |
|
782
JD.com
JD
$43.4B
| $76.9M | 0.03% |
1,277,436
-32,126
| -2% | -$1.63M |
|
783
United Natural Foods
UNFI
$3.07B
| $76.8M | 0.03% |
4,216,121
+678,797
| +19% | +$10.2M |
|
|
MRO
784
DELISTED
Marathon Oil Corporation
MRO
| $76.6M | 0.03% |
12,521,420
-6,187,759
| -33% | -$34.2M |
|
785
Arch Capital
ACGL
$36.6B
| $76.6M | 0.03% |
2,674,412
+147,393
| +6% | +$4.07M |
|
786
Qualys
QLYS
$4.71B
| $76.6M | 0.03% |
736,115
+14,999
| +2% | +$1.57M |
|
787
Nu Skin
NUS
$252M
| $76.4M | 0.03% |
1,998,920
+310,794
| +18% | +$9.99M |
|
|
MZTI
788
The Marzetti Company
MZTI
$3.02B
| $76.3M | 0.03% |
492,338
-546
| -0.1% | -$79.5K |
|
|
REGI
789
DELISTED
Renewable Energy Group, Inc.
REGI
| $75.9M | 0.03% |
3,063,610
+336,287
| +12% | +$8.52M |
|
790
Helmerich & Payne
HP
$3.35B
| $75.5M | 0.03% |
3,871,919
-387,032
| -9% | -$7.55M |
|
791
Prosperity Bancshares
PB
$8.93B
| $75.4M | 0.03% |
1,269,305
-686,117
| -35% | -$39.6M |
|
792
LPL Financial
LPLA
$27.4B
| $75.3M | 0.03% |
960,447
-9,968
| -1% | -$666K |
|
793
POSCO
PKX
$14.9B
| $75.2M | 0.03% |
2,031,183
-339,892
| -14% | -$12.4M |
|
|
MDRX
794
DELISTED
Veradigm Inc. Common Stock
MDRX
| $75.2M | 0.03% |
11,101,009
+122,647
| +1% | +$795K |
|
795
FirstCash
FCFS
$8.81B
| $74.9M | 0.03% |
1,109,938
-47,239
| -4% | -$3.33M |
|
796
Xcel Energy
XEL
$49.5B
| $74.7M | 0.03% |
1,195,350
-6,236
| -0.5% | -$393K |
|
797
Bio-Rad Laboratories Class A
BIO
$8.74B
| $74.7M | 0.03% |
165,490
+4,640
| +3% | +$2.05M |
|
798
Spectrum Brands
SPB
$2.03B
| $74.6M | 0.03% |
1,626,345
-76,850
| -5% | -$3.26M |
|
799
Repligen
RGEN
$6.95B
| $74.6M | 0.03% |
603,860
-82,331
| -12% | -$9.69M |
|
800
Rexford Industrial Realty
REXR
$8.66B
| $74.6M | 0.03% |
1,800,020
+72,041
| +4% | +$2.89M |
|
Similar funds
Dimensional Fund Advisors's Q2 2020 Portfolio in Review
As of Q2 2020, Dimensional Fund Advisors held 3,428 positions worth $228B, up 19% from $192B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Trading was light in Q2 2020: portfolio turnover was 4.2%. Dimensional Fund Advisors opened 54 new positions and exited 89, leaving the 3,428-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 16% a quarter earlier, followed by Financials and Industrials.
- Dimensional Fund Advisors's largest Q2 2020 buy was Otis Worldwide: 2,746,401 shares worth $156M.
- Dimensional Fund Advisors added most to AbbVie in Q2 2020, an estimated $214M increase.
- Dimensional Fund Advisors's biggest Q2 2020 reduction was Apple, cutting an estimated $324M.
- Dimensional Fund Advisors fully exited Allergan plc in Q2 2020, selling an estimated $259M.
- Dimensional Fund Advisors's ten largest holdings make up 12% of its $228B portfolio in Q2 2020.
- Dimensional Fund Advisors opened 54 new positions and closed 89 in Q2 2020.
- Dimensional Fund Advisors's portfolio value rose 19% quarter-over-quarter to $228B.
Based on Dimensional Fund Advisors's 13F filing for Q2 2020, filed 13 Aug 2020.